Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
- PMID: 26468341
- PMCID: PMC4600176
- DOI: 10.4239/wjd.v6.i13.1246
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
Abstract
The incidence of diabetes mellitus (DM) continues to rise and has quickly become one of the most prevalent and costly chronic diseases worldwide. A close link exists between DM and cardiovascular disease (CVD), which is the most prevalent cause of morbidity and mortality in diabetic patients. Cardiovascular (CV) risk factors such as obesity, hypertension and dyslipidemia are common in patients with DM, placing them at increased risk for cardiac events. In addition, many studies have found biological mechanisms associated with DM that independently increase the risk of CVD in diabetic patients. Therefore, targeting CV risk factors in patients with DM is critical to minimize the long-term CV complications of the disease. This paper summarizes the relationship between diabetes and CVD, examines possible mechanisms of disease progression, discusses current treatment recommendations, and outlines future research directions.
Keywords: Cardiovascular disease; Diabetes mellitus; Mechanism; Treatment.
Similar articles
-
Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies.Rev Cardiovasc Med. 2024 Dec 11;25(12):436. doi: 10.31083/j.rcm2512436. eCollection 2024 Dec. Rev Cardiovasc Med. 2024. PMID: 39742220 Free PMC article. Review.
-
Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.Front Endocrinol (Lausanne). 2018 Jan 17;9:2. doi: 10.3389/fendo.2018.00002. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29387042 Free PMC article. Review.
-
Epidemiology of Diabetes Mellitus and Cardiovascular Disease.Curr Cardiol Rep. 2019 Mar 4;21(4):21. doi: 10.1007/s11886-019-1107-y. Curr Cardiol Rep. 2019. PMID: 30828746 Review.
-
Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence.Diabetes Metab Syndr Obes. 2015 Apr 15;8:189-96. doi: 10.2147/DMSO.S49592. eCollection 2015. Diabetes Metab Syndr Obes. 2015. PMID: 25926748 Free PMC article. Review.
-
Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):508-16. doi: 10.1161/CIRCOUTCOMES.115.001717. Circ Cardiovasc Qual Outcomes. 2015. PMID: 26307132 Free PMC article.
Cited by
-
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.J Am Heart Assoc. 2022 Sep 20;11(18):e024350. doi: 10.1161/JAHA.121.024350. Epub 2022 Sep 14. J Am Heart Assoc. 2022. PMID: 36102236 Free PMC article.
-
Importance of Geospatial Heterogeneity in Chronic Disease Burden for Policy Planning in an Urban Setting Using a Case Study of Singapore.Int J Environ Res Public Health. 2021 Apr 21;18(9):4406. doi: 10.3390/ijerph18094406. Int J Environ Res Public Health. 2021. PMID: 33919144 Free PMC article.
-
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.J Diabetes Investig. 2021 Oct;12(10):1890-1898. doi: 10.1111/jdi.13548. Epub 2021 May 4. J Diabetes Investig. 2021. PMID: 33742744 Free PMC article.
-
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics.Asian J Pharm Sci. 2024 Jun;19(3):100927. doi: 10.1016/j.ajps.2024.100927. Epub 2024 May 19. Asian J Pharm Sci. 2024. PMID: 38948399 Free PMC article. Review.
-
TRAIL inhibits oxidative stress in human aortic endothelial cells exposed to pro-inflammatory stimuli.Physiol Rep. 2020 Oct;8(20):e14612. doi: 10.14814/phy2.14612. Physiol Rep. 2020. PMID: 33080110 Free PMC article.
References
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
-
- Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, Hirst M, Hwang C, Magliano D, Patterson C. IDF Diabetes Atlas. 2013.
-
- Bahia LR, Araujo DV, Schaan BD, Dib SA, Negrato CA, Leão MP, Ramos AJ, Forti AC, Gomes MB, Foss MC, et al. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 2011;14:S137–S140. - PubMed
-
- American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31:596–615. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources